Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CPRX
#1657
Catalyst Pharmaceutical Inc.
25.850
0
USD
-1.30%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.30%
Monthly Change
+10.66%
6 month change
+21.88%
Year Change
+21.88%
Previous Close
26.190
0
Open
25.850
0
Bid
Ask
Low
25.850
0
High
25.850
0
Volume
94
Markets
US Stock Market
Healthcare
CPRX
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
121.45 M
121.98 M
122.39 M
122.91 M
122.12 M
—
Valuation ratios
Enterprise value
2.02 B
2.38 B
2 B
1.73 B
2.14 B
8.25 B
Price to earnings ratio
15.93
15.45
13.15
11.45
13.89
53.94
Price to sales ratio
5.3
5.69
4.9
4.31
5.04
19.96
Price to cash flow ratio
10.87
11.35
9.95
10.62
14.23
46.16
Price to book ratio
3.58
1.09
0.9
0.76
3.11
5.86
Enterprise value to EBITDA ratio
7.46
7.53
5.78
4.44
6.43
24.17
Profitability ratios
Return on assets %
0.07
0.06
0.05
0.05
0.05
0.21
Return on equity %
0.08
0.07
0.06
0.06
0.06
0.24
Return on invested capital %
82.27
89.47
91.41
88.29
75.45
344.62
Gross margin %
84.74
87.33
85.94
84.73
82.91
340.92
Operating margin %
44.31
44.81
45.24
44.66
40.52
175.22
EBITDA margin %
77.34
58.1
64.44
69.89
71.34
263.78
Net margin %
39.44
40.12
35.55
35.57
34.53
145.77
Liquidity ratios
Quick ratio
5.01
5.96
6.55
6.4
5.82
24.74
Current ratio
5.17
6.14
6.71
6.62
6.08
25.55
Inventory turnover
1.09
0.91
1.07
0.97
0.8
3.75
Asset turnover
0.17
0.16
0.16
0.15
0.14
0.6
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.57
0.47
0.56
0.26
0.35
1.64
EBIT per share
0.58
0.57
0.59
0.59
0.56
2.32
EBITDA per share
0.88
0.65
0.74
0.82
0.86
3.06
Total debt per share
—
—
—
—
—
—
Cash per share
4.14
4.57
5.12
5.43
5.57
20.69
Net current asset value per share
4.99
5.4
5.95
6.71
7.03
25.08
Tangible book value per share
4.57
5.1
5.63
6.23
6.46
23.42
Working capital per share
4.03
4.52
5.06
5.69
5.87
21.15
Book value per share
5.82
6.26
6.71
7.24
7.5
27.71
News
TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication
NVO Inks Deal With OpenAI for Speedy Drug Discovery Globally, Stock Up
CGON Stock Up 60.8% in Six Months: Here's What You Need to Know
Does Catalyst (CPRX) Have the Potential to Rally 28.87% as Wall Street Analysts Expect?
KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data
ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study
Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes
SNY & REGN's Dupixent Gets EU Approval for Pediatric Use in Urticaria
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200
If You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now